Research Article

Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics

Table 2

Relationship between CXCR4 expression status and clinicopathological features in DLBCL.

CXCR4 negativeCXCR4 positive value

Age<60
≥60
16
15
5
8
0.426

GenderMale
Female
17
14
9
4
0.376

Ann Arbor stageI-II
III-IV
17
14
5
8
0.322

COOGCB
Non-GCB
25
6
6
7
0.022

IPI score0-1
≥2
9
22
3
10
0.686

MTOR<20%
≥20%
21
10
4
9
0.024

CD5<50%
≥50%
20
11
9
4
0.763

CD8 + T cell infiltration<20%
≥20%
14
17
8
5
0.322

C-MYC<50%
≥50%
15
16
8
5
0.426

TP53<50%
≥50%
21
10
6
7
0.180

PD-1≤1%
>1%
4
27
3
10
0.404

PD-L1≤1%
>1%
22
9
10
3
0.686

Abbreviations: COO: cell of origin.